{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:51:13Z","timestamp":1792086673750,"version":"4.4.0"},"reference-count":233,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T00:00:00Z","timestamp":1643241600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Cystic fibrosis (CF) is a life-limiting autosomal recessive multisystem disease. While its burden of morbidity and mortality is classically associated with pulmonary disease, CF also profoundly affects the gastrointestinal (GI) tract. Chronic low-grade inflammation and alterations to the gut microbiota are hallmarks of the CF intestine. The etiology of these manifestations is likely multifactorial, resulting from cystic fibrosis transmembrane conductance regulator (CFTR) dysfunction, a high-fat CF diet, and the use of antibiotics. There may also be a bidirectional pathophysiological link between intestinal inflammation and changes to the gut microbiome. Additionally, a growing body of evidence suggests that these GI manifestations may have significant clinical associations with growth and nutrition, quality of life, and respiratory function in CF. As such, the potential utility of GI therapies and long-term GI outcomes are areas of interest in CF. Further research involving microbial modulation and multi-omics techniques may reveal novel insights. This article provides an overview of the current evidence, pathophysiology, and future research and therapeutic considerations pertaining to intestinal inflammation and alterations in the gut microbiota in CF.<\/jats:p>","DOI":"10.3390\/jcm11030649","type":"journal-article","created":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T22:00:56Z","timestamp":1643320856000},"page":"649","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Intestinal Inflammation and Alterations in the Gut Microbiota in Cystic Fibrosis: A Review of the Current Evidence, Pathophysiology and Future Directions"],"prefix":"10.3390","volume":"11","author":[{"given":"Rachel Y.","family":"Tam","sequence":"first","affiliation":[{"name":"Discipline of Paediatrics & Child Health, Randwick Clinical Campus, School of Clinical Medicine, UNSW Medicine & Health, University of New South Wales, Sydney, NSW 2031, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josie M.","family":"van Dorst","sequence":"additional","affiliation":[{"name":"Discipline of Paediatrics & Child Health, Randwick Clinical Campus, School of Clinical Medicine, UNSW Medicine & Health, University of New South Wales, Sydney, NSW 2031, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"McKay","sequence":"additional","affiliation":[{"name":"Wagga Wagga Base Hospital, Wagga Wagga, NSW 2650, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5543-9438","authenticated-orcid":false,"given":"Michael","family":"Coffey","sequence":"additional","affiliation":[{"name":"Discipline of Paediatrics & Child Health, Randwick Clinical Campus, School of Clinical Medicine, UNSW Medicine & Health, University of New South Wales, Sydney, NSW 2031, Australia"},{"name":"Department of Gastroenterology, Sydney Children\u2019s Hospital Randwick, Sydney, NSW 2031, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chee Y.","family":"Ooi","sequence":"additional","affiliation":[{"name":"Discipline of Paediatrics & Child Health, Randwick Clinical Campus, School of Clinical Medicine, UNSW Medicine & Health, University of New South Wales, Sydney, NSW 2031, Australia"},{"name":"Department of Gastroenterology, Sydney Children\u2019s Hospital Randwick, Sydney, NSW 2031, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,1,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nrg3849","article-title":"Cystic fibrosis genetics: From molecular understanding to clinical application","volume":"16","author":"Cutting","year":"2015","journal-title":"Nat. Rev. Genet."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"118959","DOI":"10.1016\/j.lfs.2020.118959","article-title":"A bird eye view on cystic fibrosis: An underestimated multifaceted chronic disorder","volume":"268","author":"Kotnala","year":"2021","journal-title":"Life Sci."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev-med-112717-094536","article-title":"Cystic Fibrosis: Emerging Understanding and Therapies","volume":"70","author":"Rey","year":"2019","journal-title":"Annu. Rev. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1016\/S0140-6736(16)00576-6","article-title":"Cystic fibrosis","volume":"388","author":"Elborn","year":"2016","journal-title":"Lancet"},{"key":"ref_5","unstructured":"(2021, November 24). Cystic Fibrosis Mutation Database (CFTR1). Available online: http:\/\/www.genet.sickkids.on.ca\/."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.jcf.2019.11.003","article-title":"The genetics and genomics of cystic fibrosis","volume":"19","author":"Sharma","year":"2019","journal-title":"J. Cyst. Fibros."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nrgastro.2015.226","article-title":"Cystic fibrosis from the gastroenterologist\u2019s perspective","volume":"13","author":"Ooi","year":"2016","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"306","DOI":"10.5223\/pghn.2018.21.4.306","article-title":"Cystic Fibrosis: Clinical Phenotypes in Children and Adolescents","volume":"21","author":"Santos","year":"2018","journal-title":"Pediatr. Gastroenterol. Hepatol. Nutr."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00018-016-2393-9","article-title":"Cystic fibrosis: A clinical view","volume":"74","author":"Castellani","year":"2017","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1016\/j.jcf.2017.06.011","article-title":"Pancreatic insufficiency in Cystic Fibrosis","volume":"16","author":"Singh","year":"2017","journal-title":"J. Cyst. Fibros."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1016\/j.jcf.2017.07.004","article-title":"Pancreatitis and pancreatic cystosis in Cystic Fibrosis","volume":"16","author":"Freeman","year":"2017","journal-title":"J. Cyst. Fibros."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1053\/j.gastro.2010.09.046","article-title":"Type of CFTR Mutation Determines Risk of Pancreatitis in Patients With Cystic Fibrosis","volume":"140","author":"Ooi","year":"2011","journal-title":"Gastroenterology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1097\/MPG.0000000000002694","article-title":"Cystic Fibrosis-related Liver Disease is Associated with Increased Disease Burden and Endocrine Comorbidities","volume":"70","author":"Singh","year":"2020","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.cgh.2016.03.041","article-title":"Features of Severe Liver Disease With Portal Hypertension in Patients With Cystic Fibrosis","volume":"14","author":"Stonebraker","year":"2016","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jcf.2012.11.010","article-title":"Cirrhosis and other liver disease in cystic fibrosis","volume":"12","author":"Flass","year":"2013","journal-title":"J. Cyst. Fibros."},{"key":"ref_16","first-page":"e11215","article-title":"Liver Disease in Cystic Fibrosis: An Update","volume":"13","author":"Parisi","year":"2013","journal-title":"Zahedan J. Res. Med Sci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.2337\/dc09-0586","article-title":"Cystic fibrosis-related diabetes: Current trends in prevalence, incidence, and mortality","volume":"32","author":"Moran","year":"2009","journal-title":"Diabetes Care"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1179551419851770","DOI":"10.1177\/1179551419851770","article-title":"Cystic Fibrosis\u2013Related Diabetes: Pathophysiology and Therapeutic Challenges","volume":"12","author":"Kelsey","year":"2019","journal-title":"Clin. Med. Insights Endocrinol. Diabetes"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.1016\/j.jcf.2019.08.007","article-title":"Male reproductive health in cystic fibrosis","volume":"18","author":"Yoon","year":"2019","journal-title":"J. Cyst. Fibros."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/humupd\/dms027","article-title":"Regulation of male fertility by CFTR and implications in male infertility","volume":"18","author":"Chen","year":"2012","journal-title":"Hum. Reprod. Updat."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/S1470-2045(18)30188-8","article-title":"Risk of gastrointestinal cancers in patients with cystic fibrosis: A systematic review and meta-analysis","volume":"19","author":"Yamada","year":"2018","journal-title":"Lancet Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/jnci\/djs481","article-title":"Cancer Risk in Cystic Fibrosis: A 20-Year Nationwide Study from the United States","volume":"105","author":"Maisonneuve","year":"2012","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13073-020-0710-2","article-title":"Interactions between the gut microbiome and host gene regulation in cystic fibrosis","volume":"12","author":"Dayama","year":"2020","journal-title":"Genome Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1136\/thoraxjnl-2017-210473","article-title":"The top 10 research priorities in cystic fibrosis developed by a partnership between people with CF and healthcare providers","volume":"73","author":"Rowbotham","year":"2018","journal-title":"Thorax"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"De Palma, F.D.E., Raia, V., Kroemer, G., and Maiuri, M.C. (2020). The Multifaceted Roles of MicroRNAs in Cystic Fibrosis. Diagnostics, 10.","DOI":"10.3390\/diagnostics10121102"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1172\/JCI5731","article-title":"DeltaF508 CFTR protein expression in tissues from patients with cystic fibrosis","volume":"103","author":"Kalin","year":"1999","journal-title":"J. Clin. Investig."},{"key":"ref_27","first-page":"a009753","article-title":"The cystic fibrosis intestine","volume":"3","author":"Borowitz","year":"2013","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_28","first-page":"G82","article-title":"Physiological relevance of cell-specific distribution patterns of CFTR, NKCC1, NBCe1, and NHE3 along the crypt-villus axis in the intestine","volume":"300","author":"Jakab","year":"2011","journal-title":"Am. J. Physiol. Liver Physiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/MOG.0b013e3283358a45","article-title":"Ion transport in the small intestine","volume":"26","author":"Venkatasubramanian","year":"2010","journal-title":"Curr. Opin. Gastroenterol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.chest.2018.10.006","article-title":"The Clinical Biology of Cystic Fibrosis Transmembrane Regulator Protein: Its Role and Function in Extrapulmonary Disease","volume":"155","author":"Liou","year":"2019","journal-title":"Chest"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Scott, P., Anderson, K., Singhania, M., and Cormier, R. (2020). Cystic Fibrosis, CFTR, and Colorectal Cancer. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21082891"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1136\/adc.82.5.394","article-title":"Intestinal inflammation in cystic fibrosis","volume":"82","author":"Smyth","year":"2000","journal-title":"Arch. Dis. Child."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1203\/00006450-200003000-00010","article-title":"Evidence of Chronic Inflammation in Morphologically Normal Small Intestine of Cystic Fibrosis Patients","volume":"47","author":"Raia","year":"2000","journal-title":"Pediatr. Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/MPG.0000000000001131","article-title":"Morphological and Functional Assessment of Oesophageal Mucosa Integrity in Children With Cystic Fibrosis","volume":"62","author":"Brecelj","year":"2016","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/MPG.0b013e3181d1b013","article-title":"Evidence of Intestinal Inflammation in Patients With Cystic Fibrosis","volume":"51","author":"Werlin","year":"2010","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Flass, T., Tong, S., Frank, D.N., Wagner, B., Robertson, C., Kotter, C.V., Sokol, R.J., Zemanick, E., Accurso, F., and Hoffenberg, E. (2015). Intestinal Lesions Are Associated with Altered Intestinal Microbiome and Are More Frequent in Children and Young Adults with Cystic Fibrosis and Cirrhosis. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0116967"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/j.1365-2036.2004.02174.x","article-title":"Intestinal inflammation is a frequent feature of cystic fibrosis and is reduced by probiotic administration","volume":"20","author":"Bruzzese","year":"2004","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/1471-2431-14-133","article-title":"Calprotectin in Cystic Fibrosis","volume":"14","author":"Rumman","year":"2014","journal-title":"BMC Pediatr."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Adriaanse, M.P.M., Van Der Sande, L.J.T.M., Neucker, A.M.V.D., Menheere, P.P.C.A., Dompeling, E., Buurman, W.A., and Vreugdenhil, A.C.E. (2015). Evidence for a Cystic Fibrosis Enteropathy. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0138062"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/MPG.0000000000001544","article-title":"Fecal Calprotectin in Cystic Fibrosis and Its Relation to Disease Parameters: A Longitudinal Analysis for 12 Years","volume":"65","author":"Ellemunter","year":"2017","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Bruzzese, E., Callegari, M.L., Raia, V., Viscovo, S., Scotto, R., Ferrari, S., Morelli, L., Buccigrossi, V., Vecchio, A.L., and Ruberto, E. (2014). Disrupted Intestinal Microbiota and Intestinal Inflammation in Children with Cystic Fibrosis and Its Restoration with Lactobacillus GG: A Randomised Clinical Trial. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0087796"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.imbio.2016.11.005","article-title":"Severe disease in Cystic Fibrosis and fecal calprotectin levels","volume":"222","author":"Parisi","year":"2017","journal-title":"Immunobiology"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"fiw230","DOI":"10.1093\/femsec\/fiw230","article-title":"Impact of cystic fibrosis disease on archaea and bacteria composition of gut microbiota","volume":"93","author":"Miragoli","year":"2017","journal-title":"FEMS Microbiol. Ecol."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"de Freitas, M.B., Moreira, E.A.M., Tomio, C., Moreno, Y.M.F., Daltoe, F.P., Barbosa, E., Neto, N.L., Buccigrossi, V., and Guarino, A. (2018). Altered intestinal microbiota composition, antibiotic therapy and intestinal inflammation in children and adolescents with cystic fibrosis. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0198457"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/MPG.0000000000003173","article-title":"Gastrointestinal Factors Associated With Hospitalization in Infants With Cystic Fibrosis: Results from the BONUS Study","volume":"73","author":"Sathe","year":"2021","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Enaud, R., Hooks, K.B., Barre, A., Barnetche, T., Hubert, C., Massot, M., Bazin, T., Clouzeau, H., Bui, S., and Fayon, M. (2019). Intestinal Inflammation in Children with Cystic Fibrosis Is Associated with Crohn\u2019s-Like Microbiota Disturbances. J. Clin. Med., 8.","DOI":"10.3390\/jcm8050645"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Beaufils, F., Mas, E., Mittaine, M., Addra, M., Fayon, M., Delhaes, L., Clouzeau, H., Galode, F., Lamireau, T., and Bui, S. (2020). Increased Fecal Calprotectin is Associated with Worse Gastrointestinal Symptoms and Quality of Life Scores in Children with Cystic Fibrosis. J. Clin. Med., 9.","DOI":"10.3390\/jcm9124080"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1513\/AnnalsATS.201510-669LE","article-title":"Resolution of Intestinal Histopathology Changes in Cystic Fibrosis after Treatment with Ivacaftor","volume":"13","author":"Safe","year":"2016","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1177\/0004563216639335","article-title":"Paediatric reference ranges for faecal calprotectin: A UK study","volume":"54","author":"Davidson","year":"2017","journal-title":"Ann. Clin. Biochem."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1097\/MIB.0000000000000057","article-title":"Meta-analysis: Fecal calprotectin for assessment of inflammatory bowel disease activity","volume":"20","author":"Lin","year":"2014","journal-title":"Inflamm. Bowel. Dis."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/MPG.0000000000000683","article-title":"Intestinal Inflammation and Impact on Growth in Children With Cystic Fibrosis","volume":"60","author":"Dhaliwal","year":"2015","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jcf.2020.04.016","article-title":"Circulating CRP and calprotectin to diagnose CF pulmonary exacerbations","volume":"20","author":"Jung","year":"2021","journal-title":"J. Cyst. Fibros."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"38","DOI":"10.5114\/pg.2016.58897","article-title":"The concentration of calprotectin in the stools of children with diagnosed cystic fibrosis","volume":"12","author":"Wiecek","year":"2017","journal-title":"Gastroenterol. Rev."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1378\/chest.13-0693","article-title":"Systematic Review of Blood Biomarkers in Cystic Fibrosis Pulmonary Exacerbations","volume":"144","author":"Shoki","year":"2013","journal-title":"Chest"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Tabori, H., Arnold, C., Jaudszus, A., Mentzel, H.-J., Renz, D.M., Reinsch, S., Lorenz, M., Michl, R., Gerber, A., and Lehmann, T. (2017). Abdominal symptoms in cystic fibrosis and their relation to genotype, history, clinical and laboratory findings. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0174463"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/jpc.13921","article-title":"Practical approach to the gastrointestinal manifestations of cystic fibrosis","volume":"54","author":"Bolia","year":"2018","journal-title":"J. Paediatr. Child Health."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s11894-017-0546-0","article-title":"The Enigmatic Gut in Cystic Fibrosis: Linking Inflammation, Dysbiosis, and the Increased Risk of Malignancy","volume":"19","author":"Garg","year":"2017","journal-title":"Curr. Gastroenterol. Rep."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.biocel.2014.02.005","article-title":"Cystic fibrosis: Evidence for gut inflammation","volume":"52","author":"Munck","year":"2014","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Vij, N., Mazur, S., and Zeitlin, P.L. (2009). CFTR is a negative regulator of NFkappaB mediated innate immune response. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0004664"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"64030","DOI":"10.18632\/oncotarget.11747","article-title":"Defective CFTR- beta-catenin interaction promotes NF-kappaB nuclear translocation and intestinal inflammation in cystic fibrosis","volume":"7","author":"Liu","year":"2016","journal-title":"Oncotarget"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12950-015-0107-y","article-title":"CFTR Knockdown induces proinflammatory changes in intestinal epithelial cells","volume":"12","author":"Crites","year":"2015","journal-title":"J. Inflamm."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"4179","DOI":"10.1038\/onc.2015.483","article-title":"CFTR is a tumor suppressor gene in murine and human intestinal cancer","volume":"35","author":"Than","year":"2016","journal-title":"Oncogene"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1007\/s10620-015-3842-2","article-title":"Fecal Human beta-Defensin 2 in Children with Cystic Fibrosis: Is There a Diminished Intestinal Innate Immune Response?","volume":"60","author":"Ooi","year":"2015","journal-title":"Dig. Dis. Sci."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/MPG.0000000000002864","article-title":"Reduced Intestinal Inflammation with Lumacaftor\/Ivacaftor in Adolescents with Cystic Fibrosis","volume":"71","author":"Mittaine","year":"2020","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"17834","DOI":"10.1038\/s41598-018-36364-6","article-title":"Impact of CFTR modulation with Ivacaftor on Gut Microbiota and Intestinal Inflammation","volume":"8","author":"Ooi","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jpeds.2018.05.018","article-title":"Energy Balance and Mechanisms of Weight Gain with Ivacaftor Treatment of Cystic Fibrosis Gating Mutations","volume":"201","author":"Stallings","year":"2018","journal-title":"J. Pediatr."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"e13883","DOI":"10.1111\/nmo.13883","article-title":"Motor dysfunction of the gut in cystic fibrosis","volume":"32","author":"Malagelada","year":"2020","journal-title":"Neurogastroenterol. Motil."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.jcf.2021.05.016","article-title":"Review of Gastrointestinal Motility in Cystic Fibrosis","volume":"20","author":"Henen","year":"2021","journal-title":"J. Cyst. Fibros."},{"key":"ref_69","first-page":"341-e87","article-title":"Enteric circular muscle dysfunction in the cystic fibrosis mouse small intestine","volume":"22","author":"Sewell","year":"2010","journal-title":"Neurogastroenterol. Motil."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"De Lisle, R.C., Meldi, L., Roach, E., Flynn, M., and Sewell, R. (2009). Mast Cells and Gastrointestinal Dysmotility in the Cystic Fibrosis Mouse. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0004283"},{"key":"ref_71","first-page":"G1","article-title":"Ileal smooth muscle dysfunction and remodeling in cystic fibrosis","volume":"303","author":"Risse","year":"2012","journal-title":"Am. J. Physiol. Liver Physiol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"920","DOI":"10.3109\/00365521.2012.699548","article-title":"Gastrointestinal transit times and motility in patients with cystic fibrosis","volume":"47","author":"Hedsund","year":"2012","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.jcf.2020.06.004","article-title":"Postprandial changes in gastrointestinal function and transit in cystic fibrosis assessed by Magnetic Resonance Imaging","volume":"20","author":"Ng","year":"2021","journal-title":"J. Cyst. Fibros."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/MPG.0b013e31817e0f2c","article-title":"Altered Eicosanoid Metabolism in the Cystic Fibrosis Mouse Small Intestine","volume":"47","author":"Meldi","year":"2008","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"30926","DOI":"10.1038\/srep30926","article-title":"Expression of Cystic Fibrosis Transmembrane Conductance Regulator in Ganglia of Human Gastrointestinal Tract","volume":"6","author":"Xue","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1007\/s00535-019-01610-9","article-title":"Cystic fibrosis transmembrane conductance regulator modulates enteric cholinergic activities and is abnormally expressed in the enteric ganglia of patients with slow transit constipation","volume":"54","author":"Yeh","year":"2019","journal-title":"J. Gastroenterol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"18593","DOI":"10.1038\/s41598-019-55028-7","article-title":"Gut Microbiota in Children With Cystic Fibrosis: A Taxonomic and Functional Dysbiosis","volume":"9","author":"Coffey","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1093\/cid\/cit715","article-title":"Escherichia coli dysbiosis correlates with gastrointestinal dysfunction in children with cystic fibrosis","volume":"58","author":"Hoffman","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"ref_79","first-page":"475","article-title":"The effect of probiotics on fecal calprotectin in patients with cystic fibrosis","volume":"55","author":"Fallahi","year":"2013","journal-title":"Turk. J. Pediatr."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.jcf.2014.02.007","article-title":"Improvement of digestive health and reduction in proteobacterial populations in the gut microbiota of cystic fibrosis patients using a Lactobacillus reuteri probiotic preparation: A double blind prospective study","volume":"13","author":"Garriga","year":"2014","journal-title":"J. Cyst. Fibros."},{"key":"ref_81","first-page":"CD012949","article-title":"Probiotics for people with cystic fibrosis","volume":"1","author":"Coffey","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000447252","article-title":"Increased Intestinal Permeability and Decreased Barrier Function: Does It Really Influence the Risk of Inflammation?","volume":"1","author":"Fukui","year":"2016","journal-title":"Inflamm. Intest. Dis."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00441-013-1734-3","article-title":"Disrupted tight junctions in the small intestine of cystic fibrosis mice","volume":"355","year":"2014","journal-title":"Cell Tissue Res."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/MPG.0b013e318219c397","article-title":"Impaired Mucosal Barrier Function in the Small Intestine of the Cystic Fibrosis Mouse","volume":"53","author":"Mueller","year":"2011","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_85","first-page":"290","article-title":"Intestinal Permeability in Cystic Fibrosis in Relation to Genotype","volume":"25","author":"Hallberg","year":"1997","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1203\/00006450-199606000-00010","article-title":"Intestinal permeability in exocrine pancreatic insufficiency due to cystic fibrosis or chronic pancreatitis","volume":"39","author":"Uil","year":"1996","journal-title":"Pediatr. Res."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/S0022-3476(05)80230-6","article-title":"Correlation of intestinal lactulose permeability with exocrine pancreatic dysfunction","volume":"120","author":"Mack","year":"1992","journal-title":"J. Pediatr."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1136\/adc.65.6.585","article-title":"Small intestinal permeability and orocaecal transit time in cystic fibrosis","volume":"65","author":"Dalzell","year":"1990","journal-title":"Arch. Dis. Child."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/MOG.0b013e32816aa392","article-title":"Altered permeability in inflammatory bowel disease: Pathophysiology and clinical implications","volume":"23","author":"Mankertz","year":"2007","journal-title":"Curr. Opin. Gastroenterol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1113\/jphysiol.2011.224568","article-title":"Determinants of colonic barrier function in inflammatory bowel disease and potential therapeutics","volume":"590","author":"Hering","year":"2012","journal-title":"J. Physiol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1053\/j.gastro.2020.08.005","article-title":"Increased Intestinal Permeability Is Associated With Later Development of Crohn\u2019s Disease","volume":"159","author":"Turpin","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/mi.2016.128","article-title":"Gut permeability and mucosal inflammation: Bad, good or context dependent","volume":"10","author":"Ahmad","year":"2017","journal-title":"Mucosal Immunol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.jcf.2017.03.010","article-title":"Age-dependent variation of fecal calprotectin in cystic fibrosis and healthy children","volume":"16","author":"Garg","year":"2017","journal-title":"J. Cyst. Fibros."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jcf.2017.07.011","article-title":"Age-related levels of fecal M2-pyruvate kinase in children with cystic fibrosis and healthy children 0 to 10 years old","volume":"17","author":"Garg","year":"2018","journal-title":"J. Cyst. Fibros."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1164\/rccm.201301-0153OC","article-title":"Efficacy and safety of ivacaftor in patients aged 6 to 11 years with cystic fibrosis with a G551D mutation","volume":"187","author":"Davies","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_96","unstructured":"Bell, S.C. (2017). The Australian and New Zealand Cystic Fibrosis Nutrition Guideline Authorship Group. Nutrition Guidelines for Cystic Fibrosis in Australia and New Zealand, Thoracic Society of Australia and New Zealand."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jcf.2011.10.007","article-title":"A fat lot of good: Balance and trends in fat intake in children with cystic fibrosis","volume":"11","author":"Smith","year":"2012","journal-title":"J. Cyst. Fibros."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.jcf.2017.02.010","article-title":"Dietary intake and lipid profile in children and adolescents with cystic fibrosis","volume":"16","author":"Woestenenk","year":"2017","journal-title":"J. Cyst. Fibros."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.clnu.2013.07.011","article-title":"Dietary intake in children and adolescents with cystic fibrosis","volume":"33","author":"Woestenenk","year":"2014","journal-title":"Clin. Nutr."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.jand.2020.03.016","article-title":"Dietary Macronutrient Distribution and Nutrition Outcomes in Persons with Cystic Fibrosis: An Evidence Analysis Center Systematic Review","volume":"121","author":"McDonald","year":"2021","journal-title":"J. Acad. Nutr. Diet."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.jand.2019.01.003","article-title":"The Relative Contribution of Food Groups to Macronutrient Intake in Children with Cystic Fibrosis: A European Multicenter Assessment","volume":"119","author":"Hulst","year":"2019","journal-title":"J. Acad. Nutr. Diet."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.jcf.2018.03.011","article-title":"Dietary intake of energy-dense, nutrient-poor and nutrient-dense food sources in children with cystic fibrosis","volume":"17","author":"Sutherland","year":"2018","journal-title":"J. Cyst. Fibros."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1002\/hep4.1266","article-title":"Diet-Induced Dysbiosis and Genetic Background Synergize with Cystic Fibrosis Transmembrane Conductance Regulator Deficiency to Promote Cholangiopathy in Mice","volume":"2","author":"Debray","year":"2018","journal-title":"Hepatol. Commun."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Ding, S., Chi, M.M., Scull, B.P., Rigby, R., Schwerbrock, N.M.J., Magness, S., Jobin, C., and Lund, P.K. (2010). High-Fat Diet: Bacteria Interactions Promote Intestinal Inflammation Which Precedes and Correlates with Obesity and Insulin Resistance in Mouse. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0012191"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"28990","DOI":"10.1038\/srep28990","article-title":"High Fat Diets Induce Colonic Epithelial Cell Stress and Inflammation that is Reversed by IL-22","volume":"6","author":"Gulhane","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/lipd.12131","article-title":"Six-Week High-Fat Diet Alters the Gut Microbiome and Promotes Cecal Inflammation, Endotoxin Production, and Simple Steatosis without Obesity in Male Rats","volume":"54","author":"Crawford","year":"2019","journal-title":"Lipids"},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Kim, K.-A., Gu, W., Lee, I.-A., Joh, E.-H., and Kim, D.-H. (2012). High Fat Diet-Induced Gut Microbiota Exacerbates Inflammation and Obesity in Mice via the TLR4 Signaling Pathway. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0047713"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1136\/gutjnl-2014-309059","article-title":"Antibiotics promote inflammation through the translocation of native commensal colonic bacteria","volume":"65","author":"Knoop","year":"2016","journal-title":"Gut"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"j5145","DOI":"10.1136\/bmj.j5145","article-title":"The role of the gut microbiome in systemic inflammatory disease","volume":"360","author":"Clemente","year":"2018","journal-title":"BMJ"},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Ahmed, I., Roy, B.C., Khan, S.A., Septer, S., and Umar, S. (2016). Microbiome, Metabolome and Inflammatory Bowel Disease. Microorganisms, 4.","DOI":"10.3390\/microorganisms4020020"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"8015","DOI":"10.1128\/AEM.05933-11","article-title":"Cross-Sectional and Longitudinal Comparisons of the Predominant Fecal Microbiota Compositions of a Group of Pediatric Patients with Cystic Fibrosis and Their Healthy Siblings","volume":"77","author":"Duytschaever","year":"2011","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"e20172437","DOI":"10.1542\/peds.2017-2437","article-title":"The Role of the Microbiome in the Developmental Origins of Health and Disease","volume":"141","author":"Stiemsma","year":"2018","journal-title":"Pediatrics"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"343ra382","DOI":"10.1126\/scitranslmed.aad7121","article-title":"Antibiotics, birth mode, and diet shape microbiome maturation during early life","volume":"8","author":"Bokulich","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.chom.2015.04.004","article-title":"Dynamics and Stabilization of the Human Gut Microbiome during the First Year of Life","volume":"17","author":"Roswall","year":"2015","journal-title":"Cell Host Microbe"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41591-019-0714-x","article-title":"Fecal dysbiosis in infants with cystic fibrosis is associated with early linear growth failure","volume":"26","author":"Hayden","year":"2020","journal-title":"Nat. Med."},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Vernocchi, P., del Chierico, F., Russo, A., and Majo, F. (2018). Gut microbiota signatures in cystic fibrosis: Loss of host CFTR function drives the microbiota enterophenotype. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0208171"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"24857","DOI":"10.1038\/srep24857","article-title":"Disrupted progression of the intestinal microbiota with age in children with cystic fibrosis","volume":"6","author":"Nielsen","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13073-016-0307-y","article-title":"The healthy human microbiome","volume":"8","author":"Huttenhower","year":"2016","journal-title":"Genome Med."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.chom.2016.05.003","article-title":"Immunological Consequences of Intestinal Fungal Dysbiosis","volume":"19","author":"Wheeler","year":"2016","journal-title":"Cell Host Microbe"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.tim.2013.04.002","article-title":"The emerging world of the fungal microbiome","volume":"21","author":"Huffnagle","year":"2013","journal-title":"Trends Microbiol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"644269","DOI":"10.3389\/fimmu.2021.644269","article-title":"Impact of Early Life Nutrition on Children\u2019s Immune System and Noncommunicable Diseases Through Its Effects on the Bacterial Microbiome, Virome and Mycobiome","volume":"12","author":"Fragkou","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Thavamani, A., Salem, I., Sferra, T.J., and Sankararaman, S. (2021). Impact of Altered Gut Microbiota and Its Metabolites in Cystic Fibrosis. Metabolites, 11.","DOI":"10.3390\/metabo11020123"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"k2179","DOI":"10.1136\/bmj.k2179","article-title":"Role of the gut microbiota in nutrition and health","volume":"361","author":"Valdes","year":"2018","journal-title":"BMJ"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/nrmicro.2017.58","article-title":"The resilience of the intestinal microbiota influences health and disease","volume":"15","author":"Sommer","year":"2017","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Burke, D., Fouhy, F., Harrison, M.J., Rea, M.C., Cotter, P.D., O\u2019Sullivan, O., Stanton, C., Hill, C., Shanahan, F., and Plant, B.J. (2017). The altered gut microbiota in adults with cystic fibrosis. BMC Microbiol., 17.","DOI":"10.1186\/s12866-017-0968-8"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"7486","DOI":"10.1038\/ncomms8486","article-title":"Metabolic and metagenomic outcomes from early-life pulsed antibiotic treatment","volume":"6","author":"Nobel","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.jcf.2020.04.007","article-title":"Development of the gut microbiota in early life: The impact of cystic fibrosis and antibiotic treatment","volume":"19","author":"Kristensen","year":"2020","journal-title":"J. Cyst. Fibros."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"e00274-19","DOI":"10.1128\/JB.00274-19","article-title":"Altered Stool Microbiota of Infants with Cystic Fibrosis Shows a Reduction in Genera Associated with Immune Programming from Birth","volume":"201","author":"Antosca","year":"2019","journal-title":"J. Bacteriol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jcf.2015.08.003","article-title":"Faecal proteomics: A tool to investigate dysbiosis and inflammation in patients with cystic fibrosis","volume":"15","author":"Debyser","year":"2016","journal-title":"J. Cyst. Fibros."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1073\/pnas.1714373115","article-title":"Adaptation of commensal proliferating Escherichia coli to the intestinal tract of young children with cystic fibrosis","volume":"115","author":"Matamouros","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"22493","DOI":"10.1038\/srep22493","article-title":"Metagenomic evidence for taxonomic dysbiosis and functional imbalance in the gastrointestinal tracts of children with cystic fibrosis","volume":"6","author":"Manor","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1080\/19490976.2018.1534512","article-title":"Opportunistic bacteria confer the ability to ferment prebiotic starch in the adult cystic fibrosis gut","volume":"10","author":"Wang","year":"2019","journal-title":"Gut Microbes"},{"key":"ref_133","doi-asserted-by":"crossref","unstructured":"Meeker, S.M., Mears, K.S., Sangwan, N., Brittnacher, M.J., Weiss, E.J., Treuting, P.M., Tolley, N., Pope, C.E., Hager, K.R., and Vo, A.T. (2020). CFTR dysregulation drives active selection of the gut microbiome. PLOS Pathog., 16.","DOI":"10.1371\/journal.ppat.1008251"},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Schippa, S., Iebba, V., Santangelo, F., Gagliardi, A., de Biase, R.V., Stamato, A., Bertasi, S., Lucarelli, M., Conte, M.P., and Quattrucci, S. (2013). Cystic fibrosis transmembrane conductance regulator (CFTR) allelic variants relate to shifts in faecal microbiota of cystic fibrosis patients. PLoS ONE, 8.","DOI":"10.1371\/annotation\/a8b06cd3-c8a8-48fa-9748-b04fded4b963"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s12934-020-01482-2","article-title":"Gut microbiome as a response marker for pancreatic enzyme replacement therapy in a porcine model of exocrine pancreas insufficiency","volume":"19","author":"Ritz","year":"2020","journal-title":"Microb. Cell Factories"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1146\/annurev-micro-091313-103456","article-title":"Effects of Antibiotics on Human Microbiota and Subsequent Disease","volume":"68","author":"Keeney","year":"2014","journal-title":"Annu. Rev. Microbiol."},{"key":"ref_137","first-page":"1543","article-title":"Antibiotics and the Human Gut Microbiome: Dysbioses and Accumulation of Resistances","volume":"6","author":"Francino","year":"2015","journal-title":"Front. Microbiol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1136\/gutjnl-2016-312297","article-title":"Antibiotics as deep modulators of gut microbiota: Between good and evil","volume":"65","author":"Ianiro","year":"2016","journal-title":"Gut"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"343ra81","DOI":"10.1126\/scitranslmed.aad0917","article-title":"Natural history of the infant gut microbiome and impact of antibiotic treatment on bacterial strain diversity and stability","volume":"8","author":"Yassour","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"3216","DOI":"10.1099\/mic.0.040618-0","article-title":"Long-term impacts of antibiotic exposure on the human intestinal microbiota","volume":"156","author":"Jernberg","year":"2010","journal-title":"Microbiology"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13073-016-0294-z","article-title":"The effects of antibiotics on the microbiome throughout development and alternative approaches for therapeutic modulation","volume":"8","author":"Langdon","year":"2016","journal-title":"Genome Med."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1002\/ppul.24766","article-title":"Age and environmental exposures influence the fecal bacteriome of young children with cystic fibrosis","volume":"55","author":"Loman","year":"2020","journal-title":"Pediatr. Pulmonol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jcf.2012.10.003","article-title":"Dysbiosis of bifidobacteria and Clostridium cluster XIVa in the cystic fibrosis fecal microbiota","volume":"12","author":"Duytschaever","year":"2013","journal-title":"J. Cyst. Fibros."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.jcf.2013.06.006","article-title":"Amoxicillin-clavulanic acid resistance in fecal Enterobacteriaceae from patients with cystic fibrosis and healthy siblings","volume":"12","author":"Duytschaever","year":"2013","journal-title":"J. Cyst. Fibros."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1136\/gutjnl-2015-310376","article-title":"Proton pump inhibitors affect the gut microbiome","volume":"65","author":"Imhann","year":"2016","journal-title":"Gut"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/gutjnl-2015-310861","article-title":"Proton pump inhibitors alter the composition of the gut microbiota","volume":"65","author":"Jackson","year":"2016","journal-title":"Gut"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.jpeds.2014.12.067","article-title":"16S Community Profiling Identifies Proton Pump Inhibitor Related Differences in Gastric, Lung, and Oropharyngeal Microflora","volume":"166","author":"Rosen","year":"2015","journal-title":"J. Pediatr."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"14691","DOI":"10.1073\/pnas.1005963107","article-title":"Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa","volume":"107","author":"Cavalieri","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nature12820","article-title":"Diet rapidly and reproducibly alters the human gut microbiome","volume":"505","author":"David","year":"2014","journal-title":"Nature"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.chom.2014.11.010","article-title":"Diet Dominates Host Genotype in Shaping the Murine Gut Microbiota","volume":"17","author":"Carmody","year":"2015","journal-title":"Cell Host Microbe"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.3389\/fmicb.2018.02236","article-title":"Microbial Changes and Host Response in F344 Rat Colon Depending on Sex and Age Following a High-Fat Diet","volume":"9","author":"Lee","year":"2018","journal-title":"Front. Microbiol."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.jcmgh.2015.12.008","article-title":"Intestinal Dysbiosis Contributes to the Delayed Gastrointestinal Transit in High-Fat Diet Fed Mice","volume":"2","author":"Anitha","year":"2016","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"E5934","DOI":"10.1073\/pnas.1612559113","article-title":"High-fat diet modifies the PPAR-gamma pathway leading to disruption of microbial and physiological ecosystem in murine small intestine","volume":"113","author":"Tomas","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/MCO.0000000000000209","article-title":"Influence of high-fat diet on gut microbiota: A driving force for chronic disease risk","volume":"18","author":"Murphy","year":"2015","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3389\/fcimb.2020.00009","article-title":"The Gut-Lung Axis in Health and Respiratory Diseases: A Place for Inter-Organ and Inter-Kingdom Crosstalks","volume":"10","author":"Enaud","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/s41385-019-0160-6","article-title":"Microbes, metabolites, and the gut-lung axis","volume":"12","author":"Dang","year":"2019","journal-title":"Mucosal. Immunol."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1038\/cti.2016.17","article-title":"Regulation of immune cell function by short-chain fatty acids","volume":"5","author":"Fachi","year":"2016","journal-title":"Clin. Transl. Immunol."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00535-016-1242-9","article-title":"Microbiota metabolite short chain fatty acids, GPCR, and inflammatory bowel diseases","volume":"52","author":"Sun","year":"2017","journal-title":"J. Gastroenterol."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jpeds.2015.02.049","article-title":"Associations between Gut Microbial Colonization in Early Life and Respiratory Outcomes in Cystic Fibrosis","volume":"167","author":"Hoen","year":"2015","journal-title":"J. Pediatr."},{"key":"ref_160","doi-asserted-by":"crossref","unstructured":"Hiippala, K., Kainulainen, V., Suutarinen, M., Heini, T., Bowers, J.R., Jasso-Selles, D., Lemmer, D., Valentine, M., Barnes, R., and Engelthaler, D.M. (2020). Isolation of Anti-Inflammatory and Epithelium Reinforcing Bacteroides and Parabacteroides Spp. from A Healthy Fecal Donor. Nutrients, 12.","DOI":"10.3390\/nu12040935"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1136\/gutjnl-2020-322599","article-title":"Gut microbiota modulates COPD pathogenesis: Role of anti-inflammatory Parabacteroides goldsteinii lipopolysaccharide","volume":"71","author":"Lai","year":"2022","journal-title":"Gut"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.jpeds.2015.07.044","article-title":"Early Life Growth Trajectories in Cystic Fibrosis are Associated with Pulmonary Function at Age 6 Years","volume":"167","author":"Sanders","year":"2015","journal-title":"J. Pediatr."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"872","DOI":"10.3945\/ajcn.112.051409","article-title":"Longitudinal trends in nutritional status and the relation between lung function and BMI in cystic fibrosis: A population-based cohort study","volume":"97","author":"Stephenson","year":"2013","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1136\/thorax.57.7.596","article-title":"Relationship between nutritional status and lung function in cystic fibrosis: Cross sectional and longitudinal analyses from the German CF quality assurance (CFQA) project","volume":"57","author":"Steinkamp","year":"2002","journal-title":"Thorax"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.jpeds.2012.08.040","article-title":"Better Nutritional Status in Early Childhood Is Associated with Improved Clinical Outcomes and Survival in Patients with Cystic Fibrosis","volume":"162","author":"Yen","year":"2013","journal-title":"J. Pediatr."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fendo.2020.00025","article-title":"The Role of Short-Chain Fatty Acids from Gut Microbiota in Gut-Brain Communication","volume":"11","author":"Silva","year":"2020","journal-title":"Front. Endocrinol."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s41575-019-0157-3","article-title":"The role of short-chain fatty acids in microbiota-gut-brain communication","volume":"16","author":"Dalile","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.cell.2016.05.041","article-title":"From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites","volume":"165","author":"Koh","year":"2016","journal-title":"Cell"},{"key":"ref_169","first-page":"205","article-title":"The short chain fatty acids and lipopolysaccharides status in Sprague-Dawley rats fed with high-fat and high-cholesterol diet","volume":"69","author":"Maciejewska","year":"2018","journal-title":"J. Physiol. Pharmacol. Off. J. Pol. Physiol. Soc."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3389\/fimmu.2019.00277","article-title":"Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases","volume":"10","author":"Landskron","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1194\/jlr.R036012","article-title":"The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism","volume":"54","author":"Groen","year":"2013","journal-title":"J. Lipid Res."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41579-020-0438-4","article-title":"Gut microbial metabolites as multi-kingdom intermediates","volume":"19","author":"Krautkramer","year":"2021","journal-title":"Nat. Rev. Genet."},{"key":"ref_173","doi-asserted-by":"crossref","unstructured":"Dengler, F., Kraetzig, A., and Gabel, G. (2021). Butyrate Protects Porcine Colon Epithelium from Hypoxia-Induced Damage on a Functional Level. Nutrients, 13.","DOI":"10.3390\/nu13020305"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.chom.2015.03.005","article-title":"Crosstalk between Microbiota-Derived Short-Chain Fatty Acids and Intestinal Epithelial HIF Augments Tissue Barrier Function","volume":"17","author":"Kelly","year":"2015","journal-title":"Cell Host Microbe"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.intimp.2017.07.023","article-title":"Sodium butyrate inhibits the NF-kappa B signaling pathway and histone deacetylation, and attenuates experimental colitis in an IL-10 independent manner","volume":"51","author":"Lee","year":"2017","journal-title":"Int. Immunopharmacol."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"e1233","DOI":"10.1002\/cti2.1233","article-title":"An acetate-yielding diet imprints an immune and anti-microbial programme against enteric infection","volume":"10","author":"Yap","year":"2021","journal-title":"Clin. Transl. Immunol."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12263-019-0626-x","article-title":"Gastric infusion of short-chain fatty acids can improve intestinal barrier function in weaned piglets","volume":"14","author":"Diao","year":"2019","journal-title":"Genes Nutr."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1093\/jas\/sky459","article-title":"Infusion of sodium butyrate promotes rumen papillae growth and enhances expression of genes related to rumen epithelial VFA uptake and metabolism in neonatal twin lambs","volume":"97","author":"Liu","year":"2019","journal-title":"J. Anim. Sci."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/1462-2920.13589","article-title":"Formation of propionate and butyrate by the human colonic microbiota","volume":"19","author":"Louis","year":"2017","journal-title":"Environ. Microbiol."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1136\/gutjnl-2018-317609","article-title":"Effects of dietary fat on gut microbiota and faecal metabolites, and their relationship with cardiometabolic risk factors: A 6-month randomised controlled-feeding trial","volume":"68","author":"Wan","year":"2019","journal-title":"Gut"},{"key":"ref_181","doi-asserted-by":"crossref","unstructured":"Holota, Y., Dovbynchuk, T., Kaji, I., Vareniuk, I., Dzyubenko, N., Chervinska, T., Zakordonets, L., Stetska, V., Ostapchenko, L., and Serhiychuk, T. (2019). The long-term consequences of antibiotic therapy: Role of colonic short-chain fatty acids (SCFA) system and intestinal barrier integrity. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0220642"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"50","DOI":"10.15407\/ubj89.01.050","article-title":"Fecal short-chain fatty acids at different time points after ceftriaxone administration in rats","volume":"89","author":"Holota","year":"2017","journal-title":"Ukr. Biochem. J."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"8872","DOI":"10.1038\/s41598-019-45467-7","article-title":"Antibiotic-induced decreases in the levels of microbial-derived short-chain fatty acids correlate with increased gastrointestinal colonization of Candida albicans","volume":"9","author":"Guinan","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"124","DOI":"10.5056\/jnm16042","article-title":"Colonic Transit Time Is a Driven Force of the Gut Microbiota Composition and Metabolism: In Vitro Evidence","volume":"23","author":"Tottey","year":"2017","journal-title":"J. Neurogastroenterol. Motil."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"16093","DOI":"10.1038\/nmicrobiol.2016.93","article-title":"Colonic transit time is related to bacterial metabolism and mucosal turnover in the gut","volume":"1","author":"Roager","year":"2016","journal-title":"Nat. Microbiol."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1189\/jlb.3MR0316-106R","article-title":"A tale of two sites: How inflammation can reshape the microbiomes of the gut and lungs","volume":"100","author":"Scales","year":"2016","journal-title":"J. Leukoc. Biol."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4161\/gmic.27129","article-title":"Dysbiosis in the inflamed intestine: Chance favors the prepared microbe","volume":"5","author":"Winter","year":"2014","journal-title":"Gut. Microbes."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.chom.2007.06.010","article-title":"Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae","volume":"2","author":"Lupp","year":"2007","journal-title":"Cell Host Microbe"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1136\/gutjnl-2016-312135","article-title":"Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease","volume":"67","author":"Imhann","year":"2018","journal-title":"Gut"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.3389\/fmicb.2018.02247","article-title":"The Gut Microbiota in the Pathogenesis and Therapeutics of Inflammatory Bowel Disease","volume":"9","author":"Zuo","year":"2018","journal-title":"Front. Microbiol."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41577-019-0268-7","article-title":"Host\u2013microbiota interactions in inflammatory bowel disease","volume":"20","author":"Caruso","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1164\/rccm.201404-0703OC","article-title":"Clinical Mechanism of the Cystic Fibrosis Transmembrane Conductance Regulator Potentiator Ivacaftor in G551D-mediated Cystic Fibrosis","volume":"190","author":"Rowe","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa1105185","article-title":"A CFTR potentiator in patients with cystic fibrosis and the G551D mutation","volume":"365","author":"Ramsey","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1056\/NEJMoa1409547","article-title":"Lumacaftor\u2013Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR","volume":"373","author":"Wainwright","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1038\/ctg.2017.10","article-title":"Impact of CFTR Modulation on Intestinal pH, Motility, and Clinical Outcomes in Patients With Cystic Fibrosis and the G551D Mutation","volume":"8","author":"Gelfond","year":"2017","journal-title":"Clin. Transl. Gastroenterol."},{"key":"ref_196","doi-asserted-by":"crossref","unstructured":"Kristensen, M., Groot, K.D.W.-D., Berkers, G., Chu, M., Arp, K., Ghijsen, S., Heijerman, H., Arets, H., Majoor, C., and Janssens, H. (2021). Individual and Group Response of Treatment with Ivacaftor on Airway and Gut Microbiota in People with CF and a S1251N Mutation. J. Pers. Med., 11.","DOI":"10.3390\/jpm11050350"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.jcf.2020.12.002","article-title":"Changes in fecal microbiota with CFTR modulator therapy: A pilot study","volume":"20","author":"Pope","year":"2021","journal-title":"J. Cyst. Fibros."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/MPG.0000000000002185","article-title":"Systematic Review of Probiotics for Cystic Fibrosis Patients: Moving Forward","volume":"68","author":"Neri","year":"2019","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.clnesp.2017.01.007","article-title":"Clinical effects of probiotics in cystic fibrosis patients: A systematic review","volume":"18","author":"Declercq","year":"2017","journal-title":"Clin. Nutr. ESPEN"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jcf.2016.09.004","article-title":"Effect of probiotics on respiratory, gastrointestinal and nutritional outcomes in patients with cystic fibrosis: A systematic review","volume":"16","author":"Anderson","year":"2017","journal-title":"J. Cyst. Fibros."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s12519-017-0033-6","article-title":"Does probiotic supplementation affect pulmonary exacerbation and intestinal inflammation in cystic fibrosis: A systematic review of randomized clinical trials","volume":"13","author":"Nikniaz","year":"2017","journal-title":"World J. Pediatr."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1007\/s00431-016-2769-8","article-title":"Probiotic supplementation in children with cystic fibrosis\u2014a systematic review","volume":"175","author":"Ananthan","year":"2016","journal-title":"Eur. J. Pediatr."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1126\/science.1224820","article-title":"Intestinal Inflammation Targets Cancer-Inducing Activity of the Microbiota","volume":"338","author":"Arthur","year":"2012","journal-title":"Science"},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1053\/j.gastro.2011.01.057","article-title":"Intestinal Inflammation and Cancer","volume":"140","author":"Ullman","year":"2011","journal-title":"Gastroenterology"},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1053\/j.gastro.2010.01.058","article-title":"Inflammation and Colon Cancer","volume":"138","author":"Grivennikov","year":"2010","journal-title":"Gastroenterology"},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1056\/NEJM199011013231802","article-title":"Ulcerative colitis and colorectal cancer. A population-based study","volume":"323","author":"Ekbom","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1053\/j.gastro.2003.11.010","article-title":"Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis","volume":"126","author":"Rutter","year":"2004","journal-title":"Gastroenterology"},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"G7","DOI":"10.1152\/ajpgi.00079.2004","article-title":"Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: The role of inflammation","volume":"287","author":"Itzkowitz","year":"2004","journal-title":"Am. J. Physiol. Gastrointest. Liver. Physiol."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41586-020-2080-8","article-title":"Mutational signature in colorectal cancer caused by genotoxic pks+ E. coli","volume":"580","author":"Puschhof","year":"2020","journal-title":"Nature"},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1158\/1078-0432.CCR-13-1343","article-title":"Colonization of the Human Gut by E. coli and Colorectal Cancer Risk","volume":"20","author":"Bonnet","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1053\/j.gastro.2004.03.054","article-title":"Enhanced Escherichia coli adherence and invasion in Crohn\u2019s disease and colon cancer","volume":"127","author":"Martin","year":"2004","journal-title":"Gastroenterology"},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1007\/s00248-013-0245-9","article-title":"Dysbiosis Signature of Fecal Microbiota in Colorectal Cancer Patients","volume":"66","author":"Wu","year":"2013","journal-title":"Microb. Ecol."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1053\/j.gastro.2018.04.018","article-title":"Alterations in Enteric Virome Are Associated With Colorectal Cancer and Survival Outcomes","volume":"155","author":"Nakatsu","year":"2018","journal-title":"Gastroenterology"},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1136\/gutjnl-2018-317178","article-title":"Enteric fungal microbiota dysbiosis and ecological alterations in colorectal cancer","volume":"68","author":"Coker","year":"2019","journal-title":"Gut"},{"key":"ref_215","doi-asserted-by":"crossref","unstructured":"Metzger, R.N., Krug, A.B., and Eisen\u00e4cher, K. (2018). Enteric Virome Sensing\u2014Its Role in Intestinal Homeostasis and Immunity. Viruses, 10.","DOI":"10.3390\/v10040146"},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.3389\/fimmu.2018.02240","article-title":"Immunological Tolerance and Function: Associations Between Intestinal Bacteria, Probiotics, Prebiotics, and Phages","volume":"9","author":"Vitetta","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.chom.2019.10.009","article-title":"Whole-Virome Analysis Sheds Light on Viral Dark Matter in Inflammatory Bowel Disease","volume":"26","author":"Clooney","year":"2019","journal-title":"Cell Host Microbe"},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1136\/gutjnl-2018-318131","article-title":"Gut mucosal virome alterations in ulcerative colitis","volume":"68","author":"Zuo","year":"2019","journal-title":"Gut"},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.cell.2015.01.002","article-title":"Disease-Specific Alterations in the Enteric Virome in Inflammatory Bowel Disease","volume":"160","author":"Norman","year":"2015","journal-title":"Cell"},{"key":"ref_220","doi-asserted-by":"crossref","unstructured":"Coffey, M.J., Low, I., Stelzer-Braid, S., Wemheuer, B., Garg, M., Thomas, T., Jaffe, A., Rawlinson, W.D., and Ooi, C.Y. (2020). The intestinal virome in children with cystic fibrosis differs from healthy controls. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0233557"},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.mib.2021.04.004","article-title":"The intestinal mycobiome as a determinant of host immune and metabolic health","volume":"62","author":"Gutierrez","year":"2021","journal-title":"Curr. Opin. Microbiol."},{"key":"ref_222","first-page":"352","article-title":"Fungi in the healthy human gastrointestinal tract","volume":"8","author":"Suhr","year":"2016","journal-title":"Virulence"},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s40168-017-0373-4","article-title":"The gut mycobiome of the Human Microbiome Project healthy cohort","volume":"5","author":"Nash","year":"2017","journal-title":"Microbiome"},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.immuni.2019.05.023","article-title":"Gut Mycobiota in Immunity and Inflammatory Disease","volume":"50","author":"Li","year":"2019","journal-title":"Immunity"},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1136\/gutjnl-2015-310746","article-title":"Fungal microbiota dysbiosis in IBD","volume":"66","author":"Sokol","year":"2017","journal-title":"Gut"},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.chom.2019.01.007","article-title":"Malassezia Is Associated with Crohn\u2019s Disease and Exacerbates Colitis in Mouse Models","volume":"25","author":"Limon","year":"2019","journal-title":"Cell Host Microbe"},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"e01250-16","DOI":"10.1128\/mBio.01250-16","article-title":"Bacteriome and Mycobiome Interactions Underscore Microbial Dysbiosis in Familial Crohn\u2019s Disease","volume":"7","author":"Hoarau","year":"2016","journal-title":"mBio"},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1136\/gutjnl-2018-317791","article-title":"Fungi participate in the dysbiosis of gut microbiota in patients with primary sclerosing cholangitis","volume":"69","author":"Lemoinne","year":"2020","journal-title":"Gut"},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1172\/JCI90562","article-title":"Intestinal fungi contribute to development of alcoholic liver disease","volume":"127","author":"Yang","year":"2017","journal-title":"J. Clin. Investig."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"14600","DOI":"10.1038\/srep14600","article-title":"Obesity changes the human gut mycobiome","volume":"5","author":"Esteve","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/s41586-019-1608-2","article-title":"The fungal mycobiome promotes pancreatic oncogenesis via activation of MBL","volume":"574","author":"Aykut","year":"2019","journal-title":"Nature"},{"key":"ref_232","doi-asserted-by":"crossref","unstructured":"Hardouin, P., Chiron, R., Marchandin, H., Armengaud, J., and Grenga, L. (2021). Metaproteomics to Decipher CF Host-Microbiota Interactions: Overview, Challenges and Future Perspectives. Genes, 12.","DOI":"10.3390\/genes12060892"},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"618566","DOI":"10.3389\/fmicb.2021.618566","article-title":"Distinct Human Gut Microbial Taxonomic Signatures Uncovered With Different Sample Processing and Microbial Cell Disruption Methods for Metaproteomic Analysis","volume":"12","author":"Zapico","year":"2021","journal-title":"Front. Microbiol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/11\/3\/649\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:08:46Z","timestamp":1760134126000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/11\/3\/649"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,27]]},"references-count":233,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,2]]}},"alternative-id":["jcm11030649"],"URL":"https:\/\/doi.org\/10.3390\/jcm11030649","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,27]]}}}